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The mechanisms of renal fibrogenesis after ureteral obstruction remain unclear. We tried to primarily expand mesenchymal stem
cells from renal tissues and then investigated their role in fibrogenesis after ureteral obstruction. Unilateral ureteral obstruction was
induced by ligating the left ureteral duct of adult C57BL/6 mice. We collected the kidneys for experiments at 2, 7, and 14 days after
operation. Histological analysis showed obviously fibrotic changes in the left kidney at 7 days and further increased at 14 days after
ureteral obstruction. To expand mesenchymal stem cells, we minced the renal tissues into small explants (about 1mm3) and
cultured onto 10 cm dishes. Interestingly, the outgrowth of cells was observed significantly earlier from the explants of the
obstructed left kidney than that of the unobstructed right kidney. These expanded cells showed the potency of adipogenic,
osteogenic, and chondrogenic differentiations and positively expressed with CD44 and partly expressed with CD90, CD105, and
CD106, but negatively expressed with CD34, CD45, and FSP1, suggesting the phenotype of mesenchymal stem-like cells
(MSLCs). The mouse fibrosis RT2 profiler PCR array showed that many genes were changed over 2-fold in the MSLCs
expanded from both kidneys at 2, 7, and 14 days after operation. Interestingly, profibrotic genes were prevalently enhanced in
the left kidney with ureteral obstruction. Histological analysis also showed obviously infiltration of inflammatory cells in the left
kidney at 14 days after operation. Our data indicate the potential role of resident MSLCs in renal fibrogenesis after ureteral
obstruction, but further experiments are required to understand the relevant mechanisms.
1. Introduction
Fibrosis, a common histological feature for chronic kidney
diseases, can be induced by various pathological conditions,
such as mechanical obstruction, toxins, infections, and auto-
immune diseases [1]. As the deposition of pathological
matrix in the interstitial space and within the walls of glomer-
ular capillaries is known to accelerate kidney injury, it is crit-
ical to prevent and ameliorate the pathological fibrogenesis
for kidney disease treatment.
Actually, fibrogenesis is generally recognized as a com-
mon procedure of repair/regeneration of tissues/organs in
response to various injuries. Fibroblasts are well known
to synthesize stress fiber and to deposit extracellular
matrix [2]. Myofibroblasts and leukocytes have also been
demonstrated to involve in the process of fibrogenesis [3].
Otherwise, pericytes/perivascular cells of kidney peritubular
capillaries have recently been confirmed as matrix-forming
cells [1]. However, the cellular and molecular mechanisms of
renal fibrogenesis have not yet been completely understood.
In past decades, renal progenitor cells [4] and mesenchy-
mal stem cells [5] have been identified in the adult mamma-
lian kidney. These resident stem/progenitor cells are known
to play critical roles in maintaining the homeostasis of the
kidneys. Stem/progenitor cells of renal origin have also
showed the ability to engraft into the damaged kidneys [6],
mitigate functional loss [7], and generate nephrons de novo
[8], suggesting the potential applications for curing renal
diseases. However, few studies have investigated the role
of resident stem/progenitor cells on the process of renal
fibrogenesis. Because the repair/regeneration of the injured
organs is always accompanied with fibrogenesis, it is quite
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possible that the resident stem/progenitor cells, especially the
mesenchymal stem cells, play potential role in renal fibrogen-
esis under pathological conditions.
Experimental model of unilateral ureteral obstruction
(UUO) has provided extensive information on renal fibro-
genesis [9]. Past studies have documented solid evidence of
fibrotic lesions in the kidneys at 7 days after ureteral obstruc-
tion [9]. By using the well-established UUOmodel in healthy
mice, we tried to expand mesenchymal stem cells from
renal tissues at different times after operation. We observed
dynamic changes on the number and biological characteriza-
tions of mesenchymal stem-like cells (MSLCs) after mechan-
ical obstruction, including the enhanced expression of
profibrotic genes, which indirectly suggested the likely role
of resident MSLCs on renal fibrogenesis.
2. Materials and Methods
2.1. Experimental Animals. Adult (9-14 weeks old) male
C57BL/6 mice (CLEA Japan Inc.) were used for the
experiments. This study was approved by the Institutional
Animal Care and Use Committee of Nagasaki University (no.
1108120943-8). All animal procedures were performed in
accordance with the institutional and national criteria and
recommendations.
2.2. Unilateral Ureteral Obstruction (UUO) Model. The UUO
model was established by an identical surgical procedure as
previously described [10]. Briefly, general anesthesia was
induced to the mice by intraperitoneal injection with pento-
barbital sodium (60mg/kg). A flank incision was used to
expose the left kidney and ureter. The left ureter was ligated
with 5-0 silk suture. At 2, 7, and 14 days after operation, the
animals were sacrificed and the left kidneys were extracted
for following experiments (the obstructed group, n = 18).
The right unobstructed kidneys were also extracted to serve
as biologic controls (the unobstructed group, n = 18). The
kidneys from sham-operated animals were used as negative
controls (the sham group, n = 6).
2.3. Masson’s Trichrome Staining. To detect the fibrotic
changes, 6μm thick cryosections were made from the frozen
renal tissues embedded in Tissue-Tek optimal cutting tem-
perature compound (Sakura, Tokyo, Japan) as previously
described [11]. Masson’s trichrome staining was performed
according to the manufacturer’s protocol (Sigma-Aldrich,
St. Louis, MO, USA). The stained sections were mounted
and then imaged with a microscope (Biorevo BZ-9000;
Keyence Japan, Osaka, Japan). Fibrotic area was quantified
by calculating the positive-stained area using the Image-Pro
Plus software (version 5.1.2, Media Cybernetics Inc., Carls-
bad, CA, USA), and the mean fibrotic area of 9 randomly
selected images from three separated slides was used for
statistical analysis.
2.4. Ex Vivo Expansion of MSLCs from Renal Tissues. The
ex vivo expansion of MSLCs from renal tissues was done as
previously described [12]. In brief, freshly extracted renal tis-
sues were minced into approximately 1mm3 fragments and
cultured as “explants” on 10 cm dishes (30 fragments/dish)
coated with 15μg/ml fibronectin (Corning) solution.
Stromal-like flat cells grew out from the explants at almost
3-5 days and became confluent at approximately 16 days.
We harvested the outgrowth cells using 0.25% trypsin (Gib-
co/Life Technologies, Grand Island, NY, USA) at 14 days
after the initiation of culture. The collected cells were
counted using a NucleoCounter cell-counting device (Che-
moMetec A/S, Denmark). Cells were further expanded by cell
passage, and twice-passaged cells were used for further anal-
yses. All cells were maintained in IMDM medium (Gibco)
supplemented with 10% fetal bovine serum (HyClone) and
1% penicillin/streptomycin (Gibco) and cultured at 37°C in
a humidified atmosphere of 5% CO2 and 95% air.
2.5. Assessment of Cell Proliferation. Cell proliferation was
evaluated by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide] assay as previously described
[13]. Briefly, twice-passaged MSLCs were seeded in 96-well
culture plates at a density of 1 × 104 cells/well. After 48 hours
culture, MTT was added to the medium. The formation of
formazan from MTT in viable cells was stopped by adding
lysis buffer 24 h after the addition of MTT. The absorbance
of formazan was measured at 570 nm using a microplate
reader (Thermo Scientific, Multiskan FC, USA).
2.6. Flow Cytometry and Immunocytochemistry. The char-
acterization of ex vivo expanded cells from renal tissues
was investigated by flow cytometry as previously described
[14]. Briefly, twice-passaged cells were incubated with FITC
or PE-conjugated antibodies against CD4, CD34, CD44,
CD45, CD73, CD90, CD106, and MHC II (eBioscience),
CD105 (Abcam), and FSP1 (Millipore), for 30 minutes.
Isotype-identical antibodies served as negative control.
Quantitative analysis was performed using a FACSCalibur
flow cytometer with CellQuest software (Becton Dickinson).
Differentiation of the twice-passaged cells into adipocytes,
osteocytes, and chondrocytes was also examined by using
the Mouse Mesenchymal Stem Cell Functional Identification
Kit (R&D Systems, Minneapolis, USA), according to the
manufacturer’s instructions.
2.7. Mouse Fibrosis RT2 Profiler PCR Array. To analyze the
expression of genes related to fibrosis, we purified RNA from
the expanded cells by using ISOGEN II (NIPPON GENE).
The concentration of RNA was determined using a Nano-
Drop 2000 spectrophotometer (Thermo Fisher Scientific),
and 1μg of RNA was used to generate cDNA using the
RT2 First Strand Kit (SABiosciences, a Qiagen Company).
The mouse fibrosis RT2 Profiler PCR array was performed
according to the manufacturer’s instructions (#330231
PAMM-120ZA, SABiosciences). This PCR array profiles 84
key genes involved in dysregulated tissue remodeling during
the repair and healing of wounds. The fold change of expres-
sion was calculated using the SABiosciences web-based data
analysis program. The results represent the mean expression
of three independent samples.
2.8. Immunofluorescence Staining. To estimate the infiltra-
tion of inflammatory cells in the renal tissues, immunostain-
ing was conducted on the renal tissues. Briefly, frozen













































































































Figure 2: Dynamics of cell outgrowth from renal tissues by culturing as “explants.” (a) Representative images show the outgrowth of cells
from the “explants” of renal tissues at 3 and 7 days after planting on the dish. (b) The curve lines represent the percentages of “explants”
with cell growth at different times (days) after the initiation of culture in each group. (c) The numbers of outgrowth cells harvested at 14
days after the initiation of culture. (d) MTT assay on the proliferation of twice-passaged cells.
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sections were fixed with 4% formalin (Wako) for 10min at
room temperature. After blocking, tissue sections were incu-
bated with rat anti-mouse CD86 antibody (1 : 200 dilution,
eBioscience), rat anti-mouse F4/80 antibody (1 : 200 dilution,
eBioscience), and goat anti-mouse CD11c antibody (1 : 200
dilution, Abcam) overnight at 4°C. After washing with PBS,
tissue sections were incubated with Alexa Fluorescent
488-conjugated anti-goat Ig (1 : 200 dilution) and Alexa Fluo-
rescent 594 anti-rat Ig (1 : 200 dilution) secondary antibodies
at room temperature for 1 hour in the dark. The immunoflu-
orescence was examined under microscope (Olympus).
2.9. Statistical Analysis. All data were presented as the
mean ± SD. Statistical analysis was performed by one-way
ANOVA and followed by Tukey’s multiple comparison test
(Dr. SPSS II, Chicago, IL). A p value less than 0.05 was
accepted as significant.
3. Results
3.1. Renal Fibrosis Was Clearly Induced by Ureteral
Obstruction. As shown in the representative images of Mas-
son’s trichrome staining (Figure 1(a)), fibrotic changes were
extensively observed in the left kidney at 7 and 14 days after
ureteral obstruction. In contrast, fibrotic tissues were rarely
observed in the right kidney without ureteral obstruction.
Quantitative data showed that the fibrotic area was signifi-
cantly higher in the obstructed group than the unobstructed
group at 7 days (10 08 ± 2 21% vs. 0 78 ± 0 04%, p = 0 013;
Figure 1(b)) and 14 days (38 54 ± 1 35% vs. 0 88 ± 0 02%,
p < 0 001; Figure 1(b)) after operation.
3.2. Ureteral Obstruction Accelerated the Outgrowth of
Mesenchymal Stem-Like Cells (MSLCs) from Renal Tissues.
Although the outgrowth of cells from explants was mostly
observed at 3-5 days after culture (Figure 2(a)), some
explants from the obstructed left kidneys could clearly see
the outgrowth of cells even at 1 day after the initiation of cul-
ture. By plotting the observed time of cell outgrowth from all
explants, we could find that the cell outgrowth was signifi-
cantly earlier in the obstructed group than the unobstructed
or sham groups (p < 0 01, Figure 2(b)). We harvested and
counted the outgrowth cells at 14 days after culture. Com-
pared with the healthy kidney in the sham group, the number
of outgrowth cells in either of the obstructed group or the
unobstructed group was significantly higher at 7 and 14 days
(p < 0 01, Figure 2(c)), but not at 2 days after operation
(Figure 2(c)). The total number of outgrowth cells was not
significantly different between the obstructed group and the

























































Figure 3: Expression of CD44 and CD105 in the ex vivo expanded cells from renal tissues. Twice-passaged cells are used for measuring the
expression of CD44 (a) and CD105 (b) by flow cytometry. The representative histograms (left) and quantitative data (right) are shown.
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from explants was observed earlier in the obstructed
group. Otherwise, MTT assay also showed that the prolif-
eration of twice-passaged MSLCs was not significantly dif-
ferent between the obstructed group and the unobstructed
group (Figure 2(d), p = 0 099).
3.3. Characterizations of Ex Vivo Expanded MSLCs from the
Kidneys. These ex vivo expanded MSLCs from renal tissues
of all groups were positively expressed with CD44 (>90%)
(Figure 3(a)), partly expressed with CD105 (35-50%)
(Figure 3(b)), CD90 (6-43%), CD106 (3-10%), and CD73
(2-8%), but negatively expressed with CD34, CD45, CD4,
MHC II, and FSP1 (Figure 4(a)). In vitro assay confirmed
the potency of adipogenic, osteogenic, and chondrogenic dif-
ferentiations from the twice-passaged cells (Figure 4(b)), sug-
gesting the phenotype of mesenchymal stem-like cells.
3.4. Ureteral Obstruction Prevalently Enhanced the
Expression of Profibrotic Factors in MSLCs. Data from the
mouse fibrosis RT2 profiler PCR array showed an extensive
change on the expression of genes related to fibrogenesis in
these MSLCs expanded from either the obstructed left kidney
or the unobstructed right kidney at 2, 7, and 14 days after sur-
gery, as compared with the healthy kidney from mice
received sham operation (Figure 5). However, more genes
were up- or downregulated over 2-fold at 2, 7, and 14 days
in the obstructed group than those in the unobstructed
group, and the largest difference between groups was
observed at 7 days after operation (Figure 6(a)). We further
categorized these genes according to their biological func-
tions. Interestingly, these genes that functionally related to
the ECM structural constituents (Figure 6(b)), inflammatory
cytokines and chemokines (Figure 6(c)), and TGF-beta
superfamily members (Figure 6(e)) were voluminously chan-
ged in these MSLCs expanded from the obstructed left kidney
at 2, 7, and 14 days after operation.
By listing these genes with over 5-fold change at any time
point after operation, we noticed that the majority of these
genes encoding with profibrotic factors were predominantly
changed in these MSLCs expanded from the obstructed left
CD90 CD106 CD73 CD45
CD34
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 100 101 102 104103
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(b)
Figure 4: Phenotype characterization of ex vivo expanded cells. (a) Representative histograms of flow cytometry analysis show the
expressions of CD90, CD106, CD73, CD45, CD34, CD4, MHC II, and FSP1 in the twice-passaged cells expanded from renal tissues at 7
days after ureteral obstruction. (b) Representative images of immunofluorescent staining on the adipogenic (FABP4-positive, red),
ostogenenic (osteopontin-positive, red), and chondrogenic (collagen II-positive, red) differentiations from the twice-passaged cells. Nuclei
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Figure 5: Overall changes on the expression of genes related with fibrosis in the ex vivo expanded cells from renal tissues. The heat map shows
the overall changes of expression of genes including in the mouse fibrosis RT2 profiler PCR array. Twice-passaged cells are used for analysis,
and the expression levels are comparing to the sham group.
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kidney (Figure 7). Otherwise, many of these genes, such as
Agt, Ccl12, Col3a1, Dcn, Itgb6, and Thbs2, were temporarily
changed in these MSLCs expanded from the left kidney at
only 7 days after ureteral obstruction, but the changes of
Ccl3 and Cxcr4 were constantly observed during the 14
days of follow-up (Figure 7). The predominantly change
on the expression of profibrotic factors suggested a proba-
ble role of MSLCs in renal fibrogenesis in response to
mechanical obstruction.
3.5. The Infiltration of Inflammatory Cells in Renal Tissues.
The infiltration of inflammatory cells in renal tissues was
detected by immunofluorescence staining (Figure 8). Repre-
sentative images showed that the expressions of CD11c and
F4/80 were highlighted in the left kidney with ureteral
obstruction at 14 days after operation, but the expression
of CD86 was observed in both the obstructed left kidney
and the unobstructed right kidney. The expression of
Ly6G was detected negatively in renal tissues from all groups
(data not shown).
4. Discussion
Experimental and clinical studies have demonstrated that
mesenchymal stem cells of different origins accelerate
the repair/regeneration of damaged tissues/organs with a
reduced scar formation [5, 15]. However, mesenchymal stem
cells express abundantly with both of prefibrotic and antifi-
brotic genes [16], suggesting the dual faces of mesenchymal

















































































































































































































































































Figure 6: The number and pattern of fibrosis genes that up- and downregulated over 2-fold in the ex vivo expanded cells from renal tissues.
(a) Total numbers of genes that up- and downregulated over 2-fold in the twice-passaged MSLCs of the unobstructed and obstructed groups
when comparing to the sham group. According to the biological functions, these genes with over 2-fold change are also categorized into ECM
structural constituents and remodeling enzymes (b), inflammatory cytokines and chemokines (c), transcription factors and other factors (d),
TGF-beta superfamily members (e), cell adhesion molecules (f), and growth factors (g).
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fibrosis, this study was purposed to investigate the potential
role of resident mesenchymal stem cells in fibrogenic process
under pathological condition.
Several methods, such as microdissection or enzymatic
digestion, have been used to isolate the renal stem/progenitor
cells from the normal kidneys [17, 18]. In 2006, Plotkin and
Goligorsky have successfully isolated a clone of 4E cells from
the adult murine kidneys [17]. These 4E cells express posi-
tively with CD44, CD73, and Sca-1 and show the characteris-
tics similar to mesenchymal renal embryonic cells with
multiple differentiation potency of mesodermal lineages,
including fibroblasts and pericytes, which are known to
involve in fibrogenic process. Many previous studies have
also confirmed CD44 as a marker for mesenchymal stem cells
of renal origin [18, 19]. However, there has few of study
on the purification/expansion of stem cells from damaged
kidney tissues [20].
Agreed well with past studies [16, 17], we confirmed that
ureteral obstruction induced extensively renal fibrosis within
1 week in adult healthy mice. Two methods are popularly
used to achieve primary mesenchymal stem cells from vari-
ous solid tissues/organs. One is directly culturing the tissues
on dishes to grow mesenchymal stem-like cells as described
in this study and another is to enzymatically digest the tissues
into single-cell suspension and then purify mesenchymal
stem cells for expansion. However, it is still the absence of
consensus on the cell surface marker(s) for purifying mesen-
chymal stem cells. As it is difficult to get enough renal tissues
from patients and then digest into single-cell suspension for
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Figure 7: The fold changes of expression of representative genes. Data shows the representative genes that up- and downregulated over
5 folds in the renal tissues at any time point after unilateral ureteral obstruction.
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tissues. By culturing the renal tissues as small “explants” on
dishes, we could easily expand enough number of cells from
renal tissues of mice received either sham operation or uni-
lateral ureteral obstruction surgery. These expanded cells
from renal tissues positively expressed CD44, a popular
marker for mesenchymal stem cells of renal origin [18, 19],
and also fairly expressed with another mesenchymal stem cell
marker of CD105. As CD90 and CD73 are only the golden
markers for identifying mesenchymal stem cells from human
rather than from mouse [21], it was not surprised about the
poorly/negatively expression of CD90 and CD73 in these
expanded cells from renal tissues of mouse. However, these
twice-passaged cells from renal tissues showed the potency
of multipotent differentiations and negative expressed with
fibroblast specific marker of FSP1, which suggests a pheno-
type of mesenchymal stem-like cells. Interestingly, compared
with the kidney from sham-operated mice, unilateral ureteral
obstruction induced a dynamic change on the number and
biological characterization of resident MSLCs primarily
expanded from both kidneys.
It keeps unclear how unilateral ureteral obstruction
changes the number and biological characterization of MSLCs
even in the contralateral kidney without ureteral obstruction.
The outgrowth of cells was observed earlier from explants of
the obstructed kidney than that of the unobstructed kidney,
although the proliferative activity was not significantly differ-
ent between groups. This might be related with the different
levels of cytokines/chemokines between groups. Previous
studies have demonstrated that UUO causes a sustained
glomerular ischemia by activating the renin angiotensin sys-
tem [22], and renal ischemia is known to stimulate the pro-
liferation of stem cells [23]. Ureteral obstruction may also
increase the expression of TGF-β to induce the epithelial
mesenchymal transition of tubular epithelial cells [24]. Oth-
erwise, in response to injury, interstitial cells are required to
support the regeneration of the kidneys by assuming an
immature phenotype [25]. Therefore, it was not surprising
about the dynamic changes of resident MSLCs in both kid-
neys after unilateral ureteral obstruction.
Many genes related to fibrogenesis were up- and downreg-
ulated over 2-fold in theseMSLCs ex vivo expanded from both
kidneys after unilateral ureteral obstruction. The changed
expression of some genes in theMSLCs from the unobstructed
right kidney might be due to a pathophysiological response to
various stresses, such as surgical injury and the change of
blood flow in the kidneys. Although some genes, such as
Ccl3 and Cxcr4, changed persistently, the changes of many
genes were temporarily observed after unilateral ureteral
obstruction. We noticed that the expressions of profibrotic
factors, including the ECM structural constituents, inflamma-
tory cytokines and chemokines, and TGF-beta superfamily
members, were prevalently changed in these MSLCs ex vivo
expanded from the left kidney with ureteral obstruction. The
ECM structural constituents and TGF-beta superfamily mem-
bers are well known as direct players/regulators of fibrogen-
esis. The enhanced expression of inflammatory cytokines
and chemokines, such as Ccl3 and Cxcr4, can recruit inflam-
matory cells to participate the fibrogenic process. Actually,
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Figure 8: Infiltration of inflammatory cells in renal tissues. Representative images of immunofluorescence staining with CD86, F4/80, and
CD11c show the infiltration of inflammatory cells in renal tissues. Nuclei are counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue).
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many F4/80- and CD11c-positive cells were observed in the
left kidney with ureteral obstruction. In vitro experiments,
such as the cocultures of MSLCs with macrophages and lym-
phocytes [26], may help to understand whether the resident
MSLCs activate inflammatory cells to induce the renal fibrosis
after ureteral obstruction [21]. Although further studies are
asked to demonstrate the casually relationship between the
changes of biological characterizations of resident MSLCs
and the renal fibrosis, it is quite possible that mechanical
obstruction activates the resident MSLCs to induce profibrotic
effect in the left kidney.
This study has several limitations. First, these ex vivo
expanded MSLCs were a heterogeneous population and
showed different patterns on the expression of cell surface
markers as compared to the mesenchymal stem cells from
bone marrow and adipose tissue. Although the expression
of CD44 is quite similar among groups, we did not try to
purify the CD44-positive cells for comparison about their
gene expression profiling. Second, we did not provide direct
evidence on the correlation between the gene expression
changes in MSLCs and the renal fibrosis after ureteral
obstruction. Third, it is well known about the similarity
on biological characteristics between mesenchymal stem
cells and fibroblasts. Although the negative expression of
FSP1 in the ex vivo expanded MSLCs suggested a different
phenotype with fibroblasts, it will be better to isolate fibro-
blasts from the same renal tissues for comparison in the
study. Otherwise, it is highly required to confirm the up-
and down-regulated genes at a protein level and further
identify the key factors of regulating the renal fibrosis after
ureteral obstruction.
5. Conclusions
We successfully expanded MSLCs from the kidneys using a
simple method of tissue explant culture and found that uni-
lateral ureteral obstruction induced dynamic changes on
the number and biological characterizations of resident
MSLCs in both kidneys. The enhanced expression of profi-
brotic genes in these MSLCs from the obstructed left kidney
indirectly suggests the potential role of resident MSLCs in
renal fibrosis after ureteral obstruction. The regulation of res-
ident MSLCs may provide novel approach for the prevention
and treatment of renal fibrosis.
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